RYDAPT

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug RYDAPT contains one active pharmaceutical ingredient (API):

1 Midostaurin UNII ID912S5VON - MIDOSTAURIN

Midostaurin inhibits multiple receptor tyrosine kinases, including FLT3 and KIT kinase. Midostaurin inhibits FLT3 receptor signalling and induces cell cycle arrest and apoptosis in leukaemic cells expressing FLT3 ITD or TKD mutant receptors or over-expressing FLT3 wild type receptors. Read about Midostaurin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RYDAPT Soft capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EX10		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11505M, 11506N, 11518F, 11531X, 11552B, 11553C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526518080094101
Country: EE	Ravimiamet	Identifier(s): 1753769, 1764794
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171218001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 500476, 519755
Country: FR	Base de données publique des médicaments	Identifier(s): 67868413
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 353634
Country: HK	Department of Health Drug Office	Identifier(s): 65725
Country: IE	Health Products Regulatory Authority	Identifier(s): 89103
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8106, 8107
Country: IT	Agenzia del Farmaco	Identifier(s): 045612013, 045612025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1083947, 1084937
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 148016
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20639
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100392385
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64447001
Country: SG	Health Sciences Authority	Identifier(s): 15518P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504190151
Country: US	FDA, National Drug Code	Identifier(s): 0078-0698